Bluebird Bio Stock Analysis

BLUE Stock  USD 4.26  0.44  11.52%   
The main objective of Bluebird Bio stock analysis is to determine its intrinsic value, which is an estimate of what Bluebird Bio is worth, separate from its market price. There are two main types of Bluebird Bio's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Bluebird Bio's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Bluebird Bio's stock to identify patterns and trends that may indicate its future price movements.
The Bluebird Bio stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Bluebird Bio is usually not traded on Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day. Bluebird Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Bluebird Bio's ongoing operational relationships across important fundamental and technical indicators.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bluebird Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For information on how to trade Bluebird Stock refer to our How to Trade Bluebird Stock guide.

Bluebird Stock Analysis Notes

About 95.0% of the company shares are held by institutions such as insurance companies. The book value of Bluebird Bio was currently reported as 2.08. The company has Price/Earnings To Growth (PEG) ratio of 0.32. Bluebird Bio recorded a loss per share of 0.63. The entity had not issued any dividends in recent years. The firm had 1544:1000 split on the 5th of November 2021. bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was incorporated in 1992 and is headquartered in Cambridge, Massachusetts. Bluebird Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 518 people. For more info on Bluebird Bio please contact Nick Leschly at 339 499 9300 or go to

Bluebird Bio Quarterly Cost of Revenue

10.96 Million

Bluebird Bio Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Bluebird Bio's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Bluebird Bio or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Bluebird Bio had very high historical volatility over the last 90 days
Bluebird Bio has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 3.6 M. Net Loss for the year was (266.58 M) with loss before overhead, payroll, taxes, and interest of (247.24 M).
Bluebird Bio currently holds about 132.51 M in cash with (352.95 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.72.
Bluebird Bio has a poor financial position based on the latest SEC disclosures
Over 95.0% of the company shares are held by institutions such as insurance companies
Latest headline from Where Does Wall Street Think bluebird bio Inc Stock Will Go - InvestorsObserver

Bluebird Bio Upcoming and Recent Events

Earnings reports are used by Bluebird Bio to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Bluebird Bio previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
3rd of April 2024
Upcoming Quarterly Report
14th of May 2024
Next Financial Report
31st of December 2023
Next Fiscal Quarter End
3rd of April 2024
Next Fiscal Year End
30th of September 2023
Last Quarter Report
31st of December 2022
Last Financial Announcement

Bluebird Largest EPS Surprises

Earnings surprises can significantly impact Bluebird Bio's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Fiscal Date
Estimated EPS
Reported EPS
View All Earnings Estimates

Bluebird Bio SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Bluebird Bio prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Bluebird Bio investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Bluebird Bio specific information freely available to individual and institutional investors to make a timely investment decision.
7th of November 2023
Financial Statements and Exhibits. Results of Operations and Financial Condition
30th of October 2023
Financial Statements and Exhibits. Entry into a Material Definitive Agreement
27th of September 2023
Entry into a Material Definitive Agreement
8th of August 2023
Financial Statements and Exhibits. Regulation FD Disclosure. Results of Operations and Financial Condition. Entry into a Material Definitive Agreement
12th of July 2023
Financial Statements and Exhibits. Regulation FD Disclosure
20th of June 2023
Financial Statements and Exhibits. Submission of Matters to a Vote of Security Holders. Amendments to Articles of Incorporation or Bylaws; and/or Change in Fiscal Year
12th of June 2023
Financial Statements and Exhibits. Regulation FD Disclosure
9th of May 2023
Financial Statements and Exhibits. Results of Operations and Financial Condition

Bluebird Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 465.77 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bluebird Bio's market, we take the total number of its shares issued and multiply it by Bluebird Bio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Bluebird Profitablity

Bluebird Bio's profitability indicators refer to fundamental financial ratios that showcase Bluebird Bio's ability to generate income relative to its revenue or operating costs. If, let's say, Bluebird Bio is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Bluebird Bio's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Bluebird Bio's profitability requires more research than a typical breakdown of Bluebird Bio's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2023
Return on Investment(100.62)(103.27)
Return on Average Assets(0.50)(0.51)
Return on Average Equity(1.33)(1.37)
Return on Invested Capital(0.49)(0.51)
Return on Sales(74.37)(80.23)

Management Efficiency

Bluebird Bio has return on total asset (ROA) of (0.1501) % which means that it has lost $0.1501 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4781) %, meaning that it created substantial loss on money invested by shareholders. Bluebird Bio's management efficiency ratios could be used to measure how well Bluebird Bio manages its routine affairs as well as how well it operates its assets and liabilities. As of December 4, 2023, Return on Investment is expected to decline to -103.27. In addition to that, Return on Average Assets is expected to decline to -0.51. At present, Bluebird Bio's Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Assets Non Current is expected to grow to about 403.8 M, whereas Tax Assets are forecasted to decline to about 620.1 K.
Last ReportedProjected for 2023
Book Value per Share 2.50  2.69 
Enterprise Value over EBIT(3.00)(3.24)
Enterprise Value over EBITDA(2.99)(3.23)
Price to Book Value 2.92  2.92 
Tangible Assets Book Value per Share 6.93  7.11 
Enterprise Value785.5 M806.1 M
Tangible Asset Value544.4 M558.7 M
The analysis of Bluebird Bio's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Bluebird Bio's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Bluebird Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.

Technical Drivers

As of the 4th of December, Bluebird Bio shows the Risk Adjusted Performance of 0.0579, downside deviation of 4.77, and Mean Deviation of 3.75. Bluebird Bio technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We are able to break down and analyze data for nineteen technical drivers for Bluebird Bio, which can be compared to its rivals. Please confirm Bluebird Bio variance, maximum drawdown, as well as the relationship between the Maximum Drawdown and semi variance to decide if Bluebird Bio is priced correctly, providing market reflects its regular price of 4.26 per share. Given that Bluebird Bio has jensen alpha of 0.28, we suggest you to validate Bluebird Bio's prevailing market performance to make sure the company can sustain itself at a future point.

Bluebird Bio Price Movement Analysis

Execute Study
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Bluebird Bio middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Bluebird Bio. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Bluebird Bio Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Bluebird Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Bluebird Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Bluebird Bio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Jeffrey Walsh over three months ago
Sale by Jeffrey Walsh of 200 shares of Bluebird Bio
Jeffrey Walsh over six months ago
Sale by Jeffrey Walsh of 100 shares of Bluebird Bio

Bluebird Bio Technical and Predictive Indicators

Bluebird Bio Forecast Models

Bluebird Bio's time-series forecasting models are one of many Bluebird Bio's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Bluebird Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Bluebird Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Bluebird Bio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Bluebird shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Bluebird Bio. By using and applying Bluebird Stock analysis, traders can create a robust methodology for identifying Bluebird entry and exit points for their positions.
Last ReportedProjected for 2023
EBITDA Margin(65.68)(67.41)
Gross Margin(1.80)(1.85)
Profit Margin(66.70)(68.45)

Current Bluebird Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Bluebird analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Bluebird analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
Bluebird Bio current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Bluebird analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Bluebird stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Bluebird Bio, talking to its executives and customers, or listening to Bluebird conference calls.
Bluebird Analyst Advice Details

Bluebird Stock Analysis Indicators

Bluebird Bio stock analysis indicators help investors evaluate how Bluebird Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Bluebird Bio shares will generate the highest return on investment. By understating and applying Bluebird Bio stock analysis, traders can identify Bluebird Bio position entry and exit signals to maximize returns.
Begin Period Cash Flow206.7 M
Common Stock Shares Outstanding78.6 M
Total Stockholder Equity196.3 M
Total Cashflows From Investing Activities250.5 M
Tax Provision117 K
Property Plant And Equipment Net291.4 M
Cash And Short Term Investments181.7 M
Cash113 M
Accounts Payable25.1 M
Net Debt168.4 M
50 Day M A3.1686
Total Current Liabilities128.2 M
Other Operating Expenses285.7 M
Non Current Assets Total355.4 M
Non Currrent Assets Other52.1 M
Stock Based Compensation35.2 M
When determining whether Bluebird Bio is a strong investment it is important to analyze Bluebird Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bluebird Bio's future performance. For an informed investment choice regarding Bluebird Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bluebird Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For information on how to trade Bluebird Stock refer to our How to Trade Bluebird Stock guide.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Complementary Tools for Bluebird Stock analysis

When running Bluebird Bio's price analysis, check to measure Bluebird Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bluebird Bio is operating at the current time. Most of Bluebird Bio's value examination focuses on studying past and present price action to predict the probability of Bluebird Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bluebird Bio's price. Additionally, you may evaluate how the addition of Bluebird Bio to your portfolios can decrease your overall portfolio volatility.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Is Bluebird Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bluebird Bio. If investors know Bluebird will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bluebird Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
Revenue Per Share
Quarterly Revenue Growth
Return On Assets
Return On Equity
The market value of Bluebird Bio is measured differently than its book value, which is the value of Bluebird that is recorded on the company's balance sheet. Investors also form their own opinion of Bluebird Bio's value that differs from its market value or its book value, called intrinsic value, which is Bluebird Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bluebird Bio's market value can be influenced by many factors that don't directly affect Bluebird Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bluebird Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bluebird Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bluebird Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.